Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
VentriPoint Diagnostics ( (TSE:VPT) ) has issued an announcement.
Ventripoint Diagnostics has closed a non-brokered private placement of 10,097,720 units at $0.10 per unit, raising gross proceeds of approximately $1.01 million, with company directors and officers contributing about 13.8% of the total. Each unit consists of one common share and one warrant exercisable at $0.13 for 24 months, alongside finder’s fees and associated warrants, and the financing, treated as a related party transaction under Canadian securities rules, will be used to support sales and marketing, hiring key personnel and general working capital, subject to TSX Venture Exchange approval and a four‑month plus one day hold period on securities issued.
The most recent analyst rating on (TSE:VPT) stock is a Hold with a C$0.12 price target. To see the full list of analyst forecasts on VentriPoint Diagnostics stock, see the TSE:VPT Stock Forecast page.
Spark’s Take on TSE:VPT Stock
According to Spark, TipRanks’ AI Analyst, TSE:VPT is a Neutral.
The score is held back primarily by weak financial fundamentals (ongoing losses, cash burn, and negative equity). Technicals are moderately constructive with improving momentum, and corporate updates are directionally positive, but valuation support is limited due to negative earnings and no dividend indicated.
To see Spark’s full report on TSE:VPT stock, click here.
More about VentriPoint Diagnostics
Ventripoint Diagnostics Ltd. is a medical technology company specializing in the application of artificial intelligence to echocardiography. Its VMS+ product line uses proprietary knowledge-based reconstruction technology to deliver MRI-equivalent volumetric cardiac measurements from conventional ultrasound, offering an affordable, gold-standard alternative for cardiologists. The systems are compatible with ultrasound equipment from any vendor and have regulatory approvals in the U.S., Europe and Canada, positioning the company in the global cardiac imaging market.
Average Trading Volume: 140,457
Technical Sentiment Signal: Sell
Current Market Cap: C$20.96M
For an in-depth examination of VPT stock, go to TipRanks’ Overview page.